Keyphrases
Alzheimer's Disease
70%
Mild Cognitive Impairment
18%
Amnestic Mild Cognitive Impairment (aMCI)
13%
18F-THK5351
13%
Autosomal Dominant Alzheimer's Disease
13%
Cortical Thickness
12%
Cortical Thinning
12%
Frontotemporal Dementia
12%
Positron Emission Tomography
9%
Amyloid Deposition
9%
Amyloid beta
9%
Cerebrospinal Fluid
9%
Korean Patients
9%
Alzheimer's Disease Pathology
8%
Symptom Onset
8%
Amyloid Status
8%
Alzheimer's Disease Classification
7%
Dementia
7%
Alzheimer's Disease Patient
7%
Sporadic Alzheimer's Disease
7%
Imaging Biomarkers
7%
Amyloid PET
7%
Standardized Uptake Value
7%
Dementia Diseases
7%
Vascular Cognitive Impairment
7%
Induced Pluripotent Stem Cells (iPSCs)
6%
Neurodegeneration
6%
Alzheimer's Disease Diagnosis
6%
Early Alzheimer's Disease
6%
Tau Pathology
5%
Amyloid Accumulation
5%
Disease Progression
5%
Brain Regions
5%
Cognitive Decline
5%
Disease Pathophysiology
5%
Mutation Carriers
5%
Disease Course
5%
Cognitive Impairment
5%
Plaque
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
47%
Mild Cognitive Impairment
32%
Positron Emission Tomography
17%
Fluorine-18
16%
Positron Emission Tomography
15%
Cognitive Disorders
14%
Beta Amyloid
9%
Magnetic Resonance Imaging
8%
Magnetic Resonance Imaging
8%
Neurodegeneration
7%
Gray Matter
7%
Frontotemporal Dementia
7%
Stem Cell
6%
Parkinson's Disease
5%
Medicine and Dentistry
Alzheimer's Disease
37%
Amyloid Protein
20%
Tau
15%
Mild Cognitive Impairment
14%
Fluorine-18
11%
Polyethylene Terephthalate
10%
Positron Emission Tomography
10%
Autosomal Dominant Inheritance
9%
Cerebrospinal Fluid
7%
Biological Marker
6%
Magnetic Resonance Imaging
6%
Standardized Uptake Value
6%
Pathophysiology
5%